1. Home
  2. JVA vs CMMB Comparison

JVA vs CMMB Comparison

Compare JVA & CMMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coffee Holding Co. Inc.

JVA

Coffee Holding Co. Inc.

SELL

Current Price

$4.63

Market Cap

26.4M

ML Signal

SELL

Logo Chemomab Therapeutics Ltd.

CMMB

Chemomab Therapeutics Ltd.

SELL

Current Price

$1.39

Market Cap

20.5M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
JVA
CMMB
Founded
1971
2004
Country
United States
Israel
Employees
92
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.4M
20.5M
IPO Year
1997
2023

Fundamental Metrics

Financial Performance
Metric
JVA
CMMB
Price
$4.63
$1.39
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $15.00
AVG Volume (30 Days)
76.6K
★ 138.9K
Earning Date
09-11-2026
11-19-2026
Dividend Yield
★ 1.73%
N/A
EPS Growth
N/A
★ 101.67
EPS
★ 0.68
0.04
Revenue
★ $90,655,294.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ $6.81
$34.50
Revenue Growth
★ 17.54
N/A
52 Week Low
$2.93
$1.05
52 Week High
$5.03
$3.50

Technical Indicators

Market Signals
Indicator
JVA
CMMB
Relative Strength Index (RSI) 67.92 32.61
Support Level $4.15 $1.05
Resistance Level $4.59 $1.83
Average True Range (ATR) 0.18 0.21
MACD 0.05 -0.05
Stochastic Oscillator 79.16 27.15

Price Performance

Historical Comparison
JVA
CMMB

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

About CMMB Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.

Share on Social Networks: